What is the latest NAV of HDFC Pharma and Healthcare Fund · Regular · Growth?

The latest NAV of HDFC Pharma and Healthcare Fund · Regular · Growth is ₹20.9630 as of 15 Jul 2026.

What is the expense ratio of HDFC Pharma and Healthcare Fund · Regular · Growth?

The expense ratio (TER) of HDFC Pharma and Healthcare Fund · Regular · Growth is 2.09%.

How to invest in HDFC Pharma and Healthcare Fund · Regular · Growth?

You can invest in HDFC Pharma and Healthcare Fund · Regular · Growth online through MFU (Mutual Fund Utility) via MFGenie.ai. The minimum SIP amount is ₹100.

Sectoral / Thematic📊 BSE Healthcare Index (TRI)

HDFC Pharma and Healthcare Fund · Regular · Growth

HDFC Mutual Fund · Managed by Nikhil Mathur

#8 of 214 (1Y)

View

NAV

₹20.9630

as of 15 Jul 2026

Expense Ratio

2.09%

AUM

₹1,963 Cr

Viewing Regular · Growth

Compare Fund

Lumpsum returns (CAGR)

1Y: +19.74%
3Y: —
5Y: —
Since Inception: +30.16%

SIP returns (XIRR)

1Y: +35.75%
3Y: —
5Y: —
Since Inception: +25.64%

Not enough verified history to show honest backtest scenarios (this fund is under 3 years old).

Risk Metrics

Trailing 1 year, annualised

0.77

Sharpe Ratio

+0.15

Alpha

0.37

Beta

0.70

Sortino

15.35%

Std Dev

-11.78%

Max Drawdown

Performance Comparison

Thinking about HDFC Pharma and Healthcare Fund · Regular · Growth?

Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.

Compare with Similar Funds

Nippon India Pharma Fund · Regular · Growth

3Y: +20.32%AUM: ₹8,116 Cr

ICICI Prudential Pharma Healthcare and Diagnostics (P H D) Fund · Regular · Growth

3Y: +25.24%AUM: ₹6,565 Cr

Tata India Pharma and Healthcare Fund · Regular · Growth

3Y: +21.22%AUM: ₹1,278 Cr

Aditya Birla Sun Life Pharma and Healthcare Fund · Regular · Growth

3Y: +22.56%AUM: ₹843 Cr

ITI Pharma and Healthcare Fund · Regular · Growth

3Y: +19.03%AUM: ₹217 Cr

Compare All Sectoral / Thematic Funds View all Sectoral / Thematic funds

Fund Details

Fund HouseHDFC Mutual Fund

CategorySectoral / Thematic

Fund ManagerNikhil Mathur

BenchmarkBSE Healthcare Index (TRI) ✓

Launch Date14 Sept 2023

AMFI Code152084

Transaction facts

Min. Lumpsum₹100

Min. SIP₹100

Exit LoadIn respect of each purchase switch in of units an Exit load of 1% is payable if units are redeemed switched out within 30 days from the date of allotment No Exit Load is payable if units are redeemed switched out after 30 days from the date of allotment

Available transactions

PurchaseSIPRedeemSWPSwitchSTPDemat

Portfolio holdings

as of 31 May 2026

Holding% NAV

1Sun Pharmaceutical Industries Ltd.9.20%
2Divis Laboratories Ltd.8.02%
3Lupin Ltd.5.45%
4Max Healthcare Institute Limited5.26%
5Aster Dm Healthcare Limited5.18%
6Cipla Ltd.4.92%
7Acutaas Chemicals Limited4.50%
8Alkem Laboratories Ltd.4.36%
9Anthem Biosciences Limited4.15%
10Ipca Laboratories Ltd.3.50%

Rows per page· 32 total

Page 1/4

Investment Objective

HDFC Pharma and Healthcare Fund · Regular · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.

About This Fund

HDFC Pharma and Healthcare Fund · Regular · Growth is a Sectoral / Thematic mutual fund offered by HDFC Mutual Fund. The fund has been operational for over 2 years. It manages assets worth ₹1,963 Cr, reflecting investor confidence in the fund's strategy. The fund is managed by Nikhil Mathur. It benchmarks its performance against BSE Healthcare Index (TRI). The current expense ratio is 2.09%.

Who Should Invest?

•Investors with a high risk appetite seeking long-term wealth creation
•Investors with an investment horizon of 5 years or more
•SIP investors who can benefit from rupee cost averaging during market fluctuations